Skip to main content
OpenTrials

Clinical trial condition

Hypereosinophilic Syndrome

Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.

31 public trials 9 recruiting studies

Hypereosinophilic Syndrome trial results

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Autoimmune Diseases, +26 more
Locations
  • Research Site Aurora, Colorado, United States
  • Research Site Bethesda, Maryland, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site Northfield, New Jersey, United States
View all 45 locations
Conditions
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of Bone Marrow Nucleated Cells, +17 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • University of Utah Salt Lake City, Utah, United States
  • Fred Hutchinson cancer research center Seattle, Washington, United States
Conditions
Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Southfield, Michigan, United States
View all 91 locations